Viewing Study NCT04044950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2025-12-27 @ 4:40 AM
Study NCT ID: NCT04044950
Status: WITHDRAWN
Last Update Posted: 2020-09-22
First Post: 2019-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Papillomavirus Infections View
None Oropharyngeal Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Intratumoral Injection View
None Biomarkers View
None T Cell Receptor View
None Immunotherapy View
None Neoadjuvant therapy View